SEC Form 4 · accession 0001127602-15-007253
TOMPKINS FINANCIAL CORP · TMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rosemary G. Hyland
Officer — EVP, Human Resources
Period of report
Feb 19, 2015
Accepted (ET)
Feb 20, 2015 · 10:07 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005817
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2015 | M | 1,300 | $37.28 | A | 10,085 | D | |
| Common StockF1 | Feb 19, 2015 | F | 915 | $53.02 | D | 9,170 | D | |
| Common StockF2 | Feb 19, 2015 | F | 97 | $53.02 | D | 9,073 | D | |
| Common Stock | Feb 19, 2015 | M | 1,196 | $41.71 | A | 10,269 | D | |
| Common StockF2 | Feb 19, 2015 | F | 103 | $53.02 | D | 10,166 | D | |
| Common StockF3 | Feb 19, 2015 | F | 941 | $53.02 | D | 9,225 | D | |
| Common Stock | holding | — | — | — | 1,507 | I | 401(k)/ISOP | |
| Common Stock | holding | — | — | — | 1,331 | I | By 401(K)/ESOP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy)F4 | $37.28 | Feb 19, 2015 | M | 1,300 | D | — | Nov 29, 2017 | Common Stock | 1,300 | 0 | D |
| Stock Appreciation Rights (SAR)F5 | $41.71 | Feb 19, 2015 | M | 1,196 | D | — | Sep 17, 2019 | Common Stock | 1,196 | 564 | D |
Explanation of responses
- F1Shares withheld for Option Cost.
- F2Shares withheld for taxes.
- F3Deemed disposition of shares to the issuer to satisfy exercise price.
- F4The stock option becomes exercisable in six annual installments commencing two years after the date of grant.
- F5Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.